Ginkgo Bioworks continues to face a weak demand environment, which has contributed to a lack of growth in recent years. Learn ...

Ginkgo Bioworks recently announced a five-year partnership with the Institute for Genomic Biology at the University of Illinois Urbana-Champaign, funded by ARPA-H, to develop new phage-based ...

Ginkgo Bioworks Holdings recently unveiled a collaboration with the Institute for Genomic Biology at the University of Illinois Urbana-Champaign. This partnership marks a new chapter in the company’s ...

Ginkgo Bioworks (NYSE: DNA) today announced its partnership with the Institute for Genomic Biology at the University of Illinois Urbana-Champaign on a five-year initiative funded by the Advanced ...

The average one-year price target for Ginkgo Bioworks Holdings (NYSE:DNA) has been revised to $10.88 / share. This is a ...

The MarketWatch News Department was not involved in the creation of this content. Ginkgo provides an update on its third quarter financial results BOSTON, Nov. 6, 2025 /PRNewswire/ -- Ginkgo Bioworks ...

Ginkgo Datapoints has launched the Virtual Cell Pharmacology Initiative (VCPI), an open-source effort to create the first standardized framework for virtual cell modeling in drug discovery. By ...

Detailed price information for Emergent Biosolutions (EBS-N) from The Globe and Mail including charting and trades.

(RTTNews) - Ginkgo Bioworks Holdings, Inc. (DNA) on Thursday reported third-quarter net loss of $80.76 million or $1.45 per share, compared to $56.40 million or $1.08 per share in the comparable prior ...

Ginkgo Bioworks Holdings, Inc. ((DNA)) has held its Q3 earnings call. Read on for the main highlights of the call. Ginkgo Bioworks Holdings, Inc. recently held its earnings call, revealing a mixed ...